STAT

Opinion: Bots started sabotaging my online research. I fought back

I launched an online study aimed at understanding what influences eating behaviors and eating disorders among individuals who identify as in LGBTQ+. Little did I know I was actually launching…

I launched an online study earlier this year aimed at understanding the processes that influence eating behaviors and eating disorders among individuals who identify as LGBTQ+. Little did I know I was actually launching a battle with bots.

Online surveys and questionnaires let researchers like me collect large, geographically diverse samples relatively quickly. With the growing availability of machine learning and other big-data methods, there are few easier and more cost-efficient ways to collect data. But these tools have become targets for bots and professional survey takers, which are flooding online research and threatening data integrity.

That threat wasn’t on my mind when my study went live. It consisted of validated self-report questions to measure eating disorder behaviors, exposure to discrimination, psychological well-being, social support, and a number of demographic variables. I was interested in whether sexual orientation and gender influenced eating in ways that we have not yet conceptualized, so I developed a set of

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readChemistry
STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks